Effect of Ayurvedic drugs Durvadi Ghrita Nasya, Mukkadi Bidalaka and Rasayana Yoga internally for the treatment of diabetes related eye complications Diabetic Retinopathy.

Efficacy of Durvadi Ghrita Nasya, Mukkadi Bidalaka and Rasayana Yoga internally in the management of Pramehajanya Timira (Diabetic Retinopathy)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024798

Enrollment

100

Registered

2020-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: H359- Unspecified retinal disorder

Interventions

Intervention1: Durvadi Ghrita Nasya, Mukkadi Bidalaka and Rasayana Yoga internally: In group A 1)Durvadi Ghrita for Marsha Nasya Dose - 8 drops into each nostril for 7 days in the morning Frequency-

Eligibility

Inclusion criteria

Inclusion criteria: >Patients willing for the treatment. >Patients of 30-70 years having Type 2 (Non insulin dependent) diabetes with or without visual disturbances, but with detectable ophthalmoscopic features of Diabetic Retinopathy with blood sugar level, FBS- 126 to 220 mg/dl or PPBS-180 to 300 mg/dl with ongoing treatment.

Exclusion criteria

Exclusion criteria: >Patients who are extremely debilitating and those who are not able to withstand treatment procedures. >Patients of Type-1 Diabetes or the patients of Type-2 Diabetes taking Insulin. >High Risk Diabetic Retinopathy or those requiring emergency intervention. >Patients of Diabetic Retinopathy with media opacities like cataract, vitreous degeneration etc. which interfere with ophthalmoscopical findings. >Patients having other ocular pathologies like glaucoma, high myopia etc. >Hypertensive Retinopathy and Diabetic Retinopathy associated with pregnancy. >Patients whose BCVA is less than 6/60

Design outcomes

Primary

Measure	Time frame
Relief in signs and symptoms of Pramehajanya Timira (Diabetic Retinopathy)Timepoint: Relief in signs and symptoms of Pramehajanya Timira (Diabetic Retinopathy) after 2 months of treatment	—

Secondary

Measure	Time frame
Improvement in quality of life and social well being of patientsTimepoint: within 2 year from trial	—

Countries

India

Contacts

Public ContactDr D B Vaghela

Institute for Post Graduate Training and Research in Ayurveda

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026